NORML

FEBRUARY 22, 2019

Regulators in Iowa added two new medical cannabis qualifying conditions to the current list, ulcerative colitis (effective immediately), and severe pediatric autism with self-injurious or aggressive behaviors (effective 4/2/19). Click here to email your lawmakers in support of access in healthcare facilities. AZ resident? CA resident?

Legislation 180

Legislation Hemp Compliance Compliance 180

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

NORML

MAY 24, 2019

Governor Jared Polis (D) of Colorado signed legislation into law that allows physicians to recommend medical cannabis for any condition for which an opiate would otherwise be prescribed. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

Legislation 170

Legislation Hemp Access Patients 170

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

MMJ Recs

OCTOBER 9, 2023

As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively. They offer a wide range of high-quality MMJ products tailored to individual needs, ensuring patients have access to a variety of options for pain relief.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

MMJ Recs

FEBRUARY 21, 2024

This article delves into the impact of medical marijuana on various aspects of women’s well-being, addressing key areas such as reproductive health, menstrual health, mental health, hormonal balance, pain management, wellness, and specific health conditions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

NORML

FEBRUARY 15, 2019

The House Financial Services subcommittee on Consumer Protection and Financial Institutions held a hearing Wednesday to address the lack of access to basic banking services by state-legal marijuana businesses. House Bill 324 seeks to expand and facilitate patients’ access to medical cannabidiol (CBD) products. GA resident?

Legislation 164

Legislation Hemp Compliance Compliance 164

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. FSA/Dep Care. Pet Insurance.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

MMJ Recs

SEPTEMBER 19, 2023

Common Causes of Chronic Pain Chronic pain is a complex and often debilitating condition, and its underlying causes can vary widely. Another prevalent cause is nerve damage, often associated with conditions like diabetic neuropathy or post-shingles pain (postherpetic neuralgia). Back Pain Specialists in St.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

MMJ Recs

OCTOBER 5, 2023

Patients and industry stakeholders should stay informed about evolving regulations to ensure compliance with state laws and to promote the safe and responsible use of medical cannabis. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

MARCH 29, 2022

We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. 10] In the meantime, FDA has approved some requests for compassionate use. [11].

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 16, 2019

Phil Murphy’s Executive Order #6 tasking the DOH with reviewing all Medicinal Marijuana Program (“Program”) aspects to expand access and eliminate bureaucratic barriers. – removing “psychiatric evaluation requirement” as a condition of physician certification of minors as qualifying patients.

Programs 77

Programs Chronic Pain Marijuana Conditions 77

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis to treat ankylosing spondylitis and psoriatic arthritis among many other autoimmune conditions, mental health and the effects of chronic inflammation. I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. About CFAMM. Gerald Major.

Access 45

Access Patients Marijuana Medicine 45

PrestoDoctor

AUGUST 2, 2023

Medical cannabis has been shown to have several health benefits for a variety of conditions, including chronic pain, anxiety, PTSD and more. However, if you’re living in Iowa, accessing medical cannabis can be quite difficult. It has shown promise in alleviating symptoms associated with various medical conditions.

Conditions 52

Conditions Epilepsy Dispensary Patients 52

NORML

MARCH 22, 2019

Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 137

Legislation Hemp Patients Compliance 137

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Attorney Charles Feldmann has worked extensively with a variety of state agencies focused on enforcement, licensing, federal risk mitigation, and compliance.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

MARCH 15, 2019

1647, the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Senate Bill 34 would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. CA resident?

Legislation 146

Legislation Hemp Compliance Compliance 146

NORML

MARCH 8, 2019

North Dakota’s first medical cannabis dispensary opened its doors last week in Fargo; and registered out-of-state medical cannabis patients will now be able to access their medicine while visiting Hawaii. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 172

Legislation Patients Access Seed-To-Sale 172

Cannabis Law Report

MAY 31, 2022

Two approaches apply to commercial operations—the traditional medical path and the emerging non-medical state-regulated path, while the other two paths are better seen as non-commercial—underground therapy and religious use. Breakthrough Therapy status obtained by COMPASS Pathways and Usona Institute. Breakthrough Therapy.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

NORML

MAY 31, 2019

Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Click here to email your governor in support of medical cannabis access. Legislation is pending, Senate Bill 1286, to expand patient access to medical cannabis in Arizona.

Legislation 111

Legislation Access Banking Hemp 111

NORML

MAY 3, 2019

Governor Jay Inslee (D) of Washington signed legislation into law allowing medical cannabis to be accessed by patients on school grounds, and separate legislation allowing the production of industrial hemp in accordance with new federal hemp regulations. Click here to email your lawmakers in support of medical cannabis access.

Legislation 166

Legislation Decriminalization Hemp Patients 166

NORML

MAY 17, 2019

Legislation is pending, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access. CA resident? CA resident?

Legislation 137

Legislation Hemp Compliance Compliance 137

Cannabis Law Report

DECEMBER 8, 2021

The concept initially proposed, part of a public health approach and providing for the establishment of a system for legal access to cannabis, has slowed down due to the pandemic, but will continue to be developed. It should be possible to purchase seeds in stores in Luxembourg, imported from abroad, or online. community gardens).

Recreational 52

Recreational Seed-To-Sale Consumption Events 52

Cannabis Law Report

MARCH 1, 2022

We are looking for a legal compliance analyst/paralegal to join our team. The role would include being responsible for researching and analysing compliance policies and procedures, as well as developing and managing the compliance training programmes, and being responsible for legal administrative tasks.

Compliance 52

Compliance Compliance Legalization Research and Development 52

NORML

MARCH 29, 2019

Governor Gary Herbert (R) of Utah signed legislation into law that strengthens protections for medical cannabis patients and further improves upon the state’s new medical cannabis access program. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 168

Legislation Decriminalization Hemp Patients 168

NORML

APRIL 5, 2019

She also signed bills to allow medical cannabis to be administered to patients while at school, and a broader medical expansion bill that adds several new qualifying conditions and patient protections. Governor Jared Polis (D) of Colorado signed legislation into law to add autism as a medical cannabis qualifying condition. CA resident?

Legislation 189

Legislation Banking Hemp Compliance 189

Cannabis Law Report

JANUARY 9, 2019

“Then I saw someone with Stage 4 breast cancer end up in remission from cannabis-based therapy, someone else with skin cancer; kid after kid with seizures all being treated. The largest cause of death in South Pacific females is cervical cancer; as there is little or no access to chemotherapy or radiotherapy.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

NORML

APRIL 20, 2019

Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access. CA resident? CA resident? CO resident? DE resident?

Legislation 154

Legislation Decriminalization Hemp Compliance 154

NORML

APRIL 12, 2019

Legislation is pending, Senate Bill 24, to expand access to medical cannabis in the state. Legislation is pending, House Bill 673 / Senate Bill 1430, to expand medical cannabis access. Legislation is pending, HF 754 and SF 599, to establish an industrial hemp program to be in compliance with the new federal hemp regulations.

Legislation 150

Legislation Hemp Compliance Compliance 150

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). The institution at which the trial will be conducted gives the final approval.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

SEPTEMBER 10, 2019

Click on the image to access the full report. This came after an active debate that had been occurring both publicly and in Australian legislatures to allow expanded patient access to medicinal cannabis products. Further details on the implementation of these reforms will be published in due course. Here is the full Executive Summary.

Medicine 49

Medicine Research and Development Cultivation Access 49